BC Week In Review | Jul 22, 2002
Company News

Celltech Group, ML Lab deal

CCH and Innovata Biomed (St. Albans, U.K.), a subsidiary of MLB, terminated a 1999 deal to deliver asthma compounds budesonide and formoterol with Innovata’s Clickhaler inhaler technology. CCH will continue to promote other Clickhaler products...
BioCentury | Jul 22, 2002
Finance

Ebb & Flow

With bushel baskets of VC money chasing product companies, it's not surprising that some valuations are getting overcooked. Now some VCs are putting their money to work in select toolkit companies, because their valuations are...
BC Extra | Jul 15, 2002
Company News

MLB, Celltech terminate delivery deal

Celltech (LSE:CCH; CLL) terminated a 1999 deal with Innovata Biomed (St.Albans, U.K.), a subsidiary of MLB Laboratories (LSE:MLB), to deliver asthma compounds budesonide and formoterol with Innovata's Clickhaler inhaler technology. CCH will continue to promote...
BioCentury | Jan 10, 2000
Finance

Bigger launching pad

As IPOs get bigger, so do mezzanine rounds. Witness the $72 million raised by Orchid Biocomputer. The pharmacogenomics and microfluidics company is claiming the largest venture financing in biotech history, eclipsing the $70 million raised...
BC Week In Review | Nov 9, 1998
Clinical News

Medeva regulatory update

Medeva PLC (MDV), London, U.K.   Business: Infectious diseases, Cancer   The U.K. granted marketing approval for Asmabec beclomethasone dipropionate Clickhaler, a steroid dry powder to prevent asthma attacks. MDV holds exclusive distribution rights to...
Items per page:
1 - 5 of 5